Altuviiio (Swedish Orphan Biovitrum) Market Research Report 2026: Epidemiology, Pipeline Analysis, Market Insights & Forecasts, 2020-2025, 2025-2030F, 2035F [Yahoo! Finance]
Sanofi - American Depositary Shares (SNY)
US:NYSE Investor Relations:
sanofi.com/en/investors
Company Research
Source: Yahoo! Finance
The shift towards extended half-life therapies and enhanced patient adherence are crucial drivers, especially in regions like Europe, for advancing hemophilia care. Dublin, April 29, 2026 (GLOBE NEWSWIRE) -- The "Altuviiio Market Report 2026: Epidemiology, Pipeline Analysis, Market Insights & Forecasts" has been added to ResearchAndMarkets.com's offering. The growth in the historic period is attributed to the reliance on standard factor VIII therapies, high bleeding episode burden, and frequent infusion requirements, complemented by early adoption and expansion of hemophilia treatment centers. As we look ahead, demand for long-acting therapies, refined prophylaxis guidelines, increased pediatric treatment uptake, and innovation in clotting factor engineering signal robust advancements. Improved reimbursement frameworks further bolster this promising outlook. Industry trends for the forecast period feature a shift towards extended half-life therapies and decreased injection frequ
Show less
Read more
Impact Snapshot
Event Time:
SNY
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
SNY alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
SNY alerts
High impacting Sanofi - American Depositary Shares news events
Weekly update
A roundup of the hottest topics
SNY
News
- Press Release: Annual General Meeting of April 29, 2026 - Belén Garijo appointed as Director and Chief Executive Officer of Sanofi [Yahoo! Finance]Yahoo! Finance
- Press Release: Annual General Meeting of April 29, 2026 - Belén Garijo appointed as Director and Chief Executive Officer of SanofiGlobeNewswire
- Regeneron Pharmaceuticals: Q1 Beat Driven By Dupixent And Eylea HD Strength [Seeking Alpha]Seeking Alpha
- Regeneron beats quarterly results estimates on strong Dupixent demand [Yahoo! Finance]Yahoo! Finance
- Regeneron beats first quarter estimates on Dupixent strength [Yahoo! Finance]Yahoo! Finance
SNY
Sec Filings
- 4/29/26 - Form 6-K
- 4/27/26 - Form 6-K
- 4/23/26 - Form 6-K
- SNY's page on the SEC website